A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies

NCT01416623 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Cancer

Interventions

DRUG: henatinib

Sponsor

Jiangsu HengRui Medicine Co., Ltd.